At Benchling, we’re privileged to work with some of the most innovative biotechnology and pharmaceutical companies in the world. From California, to Korea, to the Netherlands, companies developing large molecule-based products rely on Benchling to accelerate R&D and generate unprecedented business insights.
We spoke with some of our clients to hear how they:
- Double their R&D productivity
- Reduce emails sent by 66%
- Cut IND filing time in half
- Unlock their data to answer questions they were never able to answer before
In this eBook, we cover stories from Incyte, Intellia Therapeutics, Synlogic, Zymergen, Agenus, and Obsidian Therapeutics.